Literature DB >> 1670999

Allelotype of renal cell carcinoma.

R Morita1, J Ishikawa, M Tsutsumi, K Hikiji, Y Tsukada, S Kamidono, S Maeda, Y Nakamura.   

Abstract

Several recent studies based on restriction fragment length polymorphism analysis have supported the concept that the accumulation of multiple genetic alterations converts a normal cell to a malignant cell. Activation of oncogenes and/or inactivation of tumor suppressor genes have been observed during tumor progression in colorectal cancer, lung cancer, and breast cancer. To investigate the possibility that multiple genes are altered during the progression of renal cell carcinoma, we have used restriction fragment length polymorphism markers throughout the genome to test for loss of heterozygosity in 38 renal cell carcinomas. Nearly 64% of the tumors had lost heterozygosity on the short arm of chromosome 3. We also observed loss of heterozygosity averaging about 30% at informative loci on six other chromosomal arms (chromosomes 5q, 6q, 10q, 11q, 17p, and 19p). These results lead us to suspect the existence of several tumor suppressor genes associated with carcinogenesis of renal cell carcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 1670999

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization.

Authors:  A Szeles; S Bajalica-Lagercrantz; A Lindblom; T Lushnikova; V I Kashuba; S Imreh; M Nordenskjöld; G Klein; E R Zabarovsky
Journal:  Chromosome Res       Date:  1996-06       Impact factor: 5.239

2.  Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.

Authors:  P Hadaczek; J Podolski; A Toloczko; G Kurzawski; A Sikorski; P Rabbitts; K Huebner; J Lubinski
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

3.  Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.

Authors:  Kwong Wai Choy; Tom C Lee; Kin Fai Cheung; Dorothy S P Fan; Kwok Wai Lo; Katherine L Beaverson; David H Abramson; Dennis S C Lam; Christopher B O Yu; Chi Pui Pang
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

4.  Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.

Authors:  Y Suzuki; G Tamura; C Maesawa; T Fujioka; T Kubo; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.

Authors:  C A Thrash-Bingham; R E Greenberg; S Howard; A Bruzel; M Bremer; A Goll; H Salazar; J J Freed; K D Tartof
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10.

Authors:  R S Yeung; K H Buetow; J R Testa; A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Infrequent alteration of the DPC4 tumor suppressor gene in renal cell carcinoma.

Authors:  Marijana Popović Hadzija; Reno Hrasćan; Maja Herak Bosnar; Zarko Zeljko; Mirko Hadzija; Josip Cadez; Kresimir Pavelić; Sanja Kapitanović
Journal:  Urol Res       Date:  2004-04-24

Review 8.  The adenomatous polyposis coli gene and human cancers.

Authors:  Y Nakamura
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Loss of heterozygosity and methylation of p16 in renal cell carcinoma.

Authors:  M T Sanz-Casla; M L Maestro; V del Barco; I Zanna; J Moreno; M Vidaurreta; I Almansa; C Fernández; J Blanco; C Maestro; L Resel
Journal:  Urol Res       Date:  2003-03-25

10.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.